Susquehanna International Group
MRVI icon

Susquehanna International Group’s Maravai LifeSciences MRVI Stock Holding History

Susquehanna International Group’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$770K Buy
+272,000
New +$922K ﹤0.01% 8573
2025
Q3 		– Sell
-25,000
Closed -$60.3K – 13348
2025
Q2 		$60.3K Sell
25,000
-110,500
-82% -$232K ﹤0.01% 12051
2025
Q1 		$299K Buy
135,500
+118,000
+674% +$466K ﹤0.01% 10073
2024
Q4 		$95.4K Buy
17,500
+3,400
+24% +$21.9K ﹤0.01% 11377
2024
Q3 		$117K Buy
+14,100
New +$122K ﹤0.01% 10938
2024
Q2 		– Sell
-125,200
Closed -$1.09M – 12808
2024
Q1 		$1.09M Sell
125,200
-66,700
-35% -$451K ﹤0.01% 6700
2023
Q4 		$1.26M Buy
191,900
+121,700
+173% +$786K ﹤0.01% 6423
2023
Q3 		$702K Sell
70,200
-125,000
-64% -$1.37M ﹤0.01% 7441
2023
Q2 		$2.43M Buy
195,200
+183,500
+1,568% +$2.48M ﹤0.01% 4752
2023
Q1 		$164K Sell
11,700
-20,800
-64% -$299K ﹤0.01% 10827
2022
Q4 		$465K Buy
+32,500
New +$512K ﹤0.01% 8063
2022
Q2 		– Sell
-40,200
Closed -$1.42M – 13566
2022
Q1 		$1.42M Sell
40,200
-12,900
-24% -$432K ﹤0.01% 6278
2021
Q4 		$2.23M Sell
53,100
-10,200
-16% -$413K ﹤0.01% 5263
2021
Q3 		$3.11M Buy
63,300
+36,300
+134% +$1.77M ﹤0.01% 4882
2021
Q2 		$1.13M Sell
27,000
-23,300
-46% -$903K ﹤0.01% 7437
2021
Q1 		$1.79M Buy
50,300
+38,600
+330% +$1.28M ﹤0.01% 6189
2020
Q4 		$328K Buy
+11,700
New +$326K ﹤0.01% 9097

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group's MRVI Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Maravai LifeSciences (MRVI) in Q1 2026: 186,639 shares worth $528K. The stake represents ﹤0.01% of the portfolio and ranks #9527 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in MRVI as recently as Q3 2025.

Susquehanna International Group first reported a position in MRVI in Q1 2021 and has held it in 20 quarters since. The position peaked at $30.3M in Q2 2023. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Susquehanna International Group held 186,639 shares of Maravai LifeSciences worth $528K as of Q1 2026.
  • Maravai LifeSciences was a new Susquehanna International Group position in Q1 2026.
  • Maravai LifeSciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9527 holding.
  • Susquehanna International Group first reported a position in Maravai LifeSciences in Q1 2021 and has held it in 20 quarters since.
  • Susquehanna International Group's Maravai LifeSciences position peaked at $30.3M in Q2 2023.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.